Most advances in drug development originate in academia but universities struggle to translate their discoveries into novel therapeutics. We aim to create a virtual accelerator platform that helps scientists bridge the valley of death and bring more diverse treatments to patients. We are building a global network of researchers, experts and partners to create a new and more scalable process for translational science.
Co-Founder & CEO
Co-Founder & Chief Scientist
Co-Founder & CPO
Director at Open Source Initiative
Former CMO of the Linux Foundation
Licensing & High-Tech Intellectual Property Expert
Associate Fellow at the Centre for the Advancement of Sustainable Medical Innovation at Oxford University
Intellectual Property Expert, Assistant Professor at Harvard Medical School
Associate Professor at the University of Copenhagen
